Structural characteristics of short peptides in solution.

Satoshi Ohtake, Yoshiko Kita, Robert Payne, Mark Manning, Tsutomu Arakawa

Journal: Protein and peptide letters 2014;20(12):1308-23

PMID: 24261976

Abstract

Short peptides are important biopharmaceuticals as agonistic or antagonistic ligands, aggregation inhibitors, and vaccines, as well as in many other applications. They behave differently from globular proteins in solution. Many short peptides are unstructured and tend to aggregate and undergo structural transition in response to changes in solvent environment, including pH, temperature, ionic strength, presence of organic solvents or surfactants, and exposure to lipid membranes. Such structural transitions are often associated with fibril or β-amyloid formation. These structural characteristics of short peptides have drastic impact on their function, immunogenicity, and storage stability.

Address: Pfizer, 700 Chesterfield Parkway West, Chesterfield, MO 63017, USA. [email protected].

Link outs

Free resources

Other Literature Sources:

Subscription / membership required

Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.